Key facts
- This page summarizes Michael Schmertzler's Form 4 filing for PTC THERAPEUTICS, INC. (PTCT).
- 5 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Aug 2026, 17:20.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
No transaction description listed
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by Section Six Partners, L.P., of which the Reporting Person is a general partner and limited partner, on May 14, 2026
Footnote F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.33 to $73.32 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Footnote F3
Represents shares of common stock held by Section Six Partners, L.P. The Reporting Person is a general and limited partner of Section Six Partners, L.P. The Reporting Person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein.
Footnote F4
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $73.33 to $74.02 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Footnote F5
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.50 to $71.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Footnote F6
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $71.50 to $72.46 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Footnote F7
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.60 to $73.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.